BNE
Bone Medical
- Short interest
- 0.03%
- as of 7 Oct 2015
- Reported shorts
- 83K
- Shares on issue
- 257.797M
Bone Medical (BNE) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for BNE (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Botanix Quarterly Activities Report and Appendix 4C Q3 FY26Quarterly Report29 Apr 2026via asx_announcements
- Botanix 2026 Half Year Investor PresentationHalf Year Results3 Mar 2026via asx_announcements
- Correction - Appendix 4DHalf Year Results2 Mar 2026via asx_announcements
- Appendix 4D and Half Year ReportHalf Year Results27 Feb 2026via asx_announcements
- Botanix Quarterly Activities Report and Appendix 4C Q2 FY26Quarterly Report27 Jan 2026via asx_announcements
- Botanix Quarterly Activities Report and Appendix 4C Q1 FY26Quarterly Report20 Oct 2025via asx_announcements
- Appendix 4E & Annual Report for the Year Ended 30 June 2025Annual Results29 Aug 2025via asx_announcements
- June 2025 Quarterly Activities Report and Appendix 4CQuarterly Report28 Jul 2025via asx_announcements
- March 2025 Quarterly Activities Report and Appendix 4CQuarterly Report24 Apr 2025via asx_announcements
- Appendix 4D and Half Year ReportHalf Year Results26 Feb 2025via asx_announcements
Showing 10 of 19 reports